Live Breaking News & Updates on Protara Therapeutics

Stay updated with breaking news from Protara therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Protara Therapeutics to Participate in Upcoming Investor Conferences

Protara Therapeutics to Participate in Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Protara Therapeutics Inc Nasdaq , Protara Therapeutics Inc , Company Contact , Healthcare Life Sciences Conference , Healthcare Talks , Annual Biotechnology , Annual Healthcare Life Sciences , Protara Therapeutics , Inc Protara , Bacillus Calmette Gu , Justineo Malleyprotara Therapeutics ,

Post-Hoc Analysis Confirms Consistent Clinical Benefit With Olaparib Plus Abiraterone in HRR-Mutated mCRPC

Olaparib plus abiraterone acetate delayed disease progression and improved outcomes in patients with BRCA-, ATM- and CDK12-mutated mCRPC. ....

United States , Bristol Myers Squibb , Bristol Myers Squibb Sanofi , Medivation Astellas , Immunitybio Incyte , Merck Serono , Nonagen Bioscience , Astellas Pharma , Jiangsu Yahong Meditech , Telix Pharmaceuticals , Carolina Urologic Research Center , Asieris Pharmaceuticals , Foundation Medicine , Clarity Pharmaceuticals , Aragon Pharmaceuticals , Speciality Networks , Myovant Sciences , Palette Life Sciences , Guardant Health , Bureau For Astellas Pharma , Platformq Health , Boston Scientific , Janssen Scientific Affairs , Cmt Group , Neal Shore , Genesiscare United States ,

CG Oncology's Lead Bladder Cancer Drug Offers Buyout Optionality (CGON)

CG Oncology's Lead Bladder Cancer Drug Offers Buyout Optionality (CGON)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United States , Bristol Myers Squibb , Merck Keytruda , Janus Henderson , Morgan Stanley , Goldman Sachs , Bladder Cancer Advocacy Network , Cg Oncology Inc , Rayzebio Inc , Immunitybio Inc , End Drug Shortages Alliance , Pfizer Inc , Merck Co Inc , Cantor Fitzgerald , Bristol Myers Squibb Company , Protara Therapeutics Inc , Bladder Cancer , Editor Note , Sesen Bio , Bacillus Calmette Gu , Fast Track , Breakthrough Therapy , Ferring Pharmaceutical Adstiladrin , Evaluate Pharma , Protara Therapeutics ,

Protara Therapeutics (NASDAQ:TARA) Stock Price Up 1.6%

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report)’s share price rose 1.6% during mid-day trading on Thursday . The company traded as high as $2.02 and last traded at $1.91. Approximately 34,962 shares were traded during trading, an increase of 6% from the average daily volume of 32,991 shares. The stock had previously closed at […] ....

Protara Therapeutics Inc , Privium Fund Management , Virtu Financial , Renaissance Technologies , Protara Therapeutics , Get Free Report , Therapeutics Stock Down , Protara Therapeutics Daily , Nasdaq Tara ,

Protara Therapeutics (NASDAQ:TARA) Trading Up 1.6%

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report)’s stock price traded up 1.6% during trading on Thursday . The stock traded as high as $2.02 and last traded at $1.91. 34,962 shares were traded during trading, an increase of 6% from the average session volume of 32,991 shares. The stock had previously closed at $1.88. […] ....

Virtu Financial , Renaissance Technologies , Privium Fund Management , Protara Therapeutics Inc , Protara Therapeutics , Get Free Report , Protara Therapeutics Daily , Nasdaq Tara ,